Developing innovative medicines often involves intricate small-molecule APIs with lengthy synthetic routes. This complexity can significantly delay preclinical development and create challenges for supply chains. At Lonza Small Molecules, we've developed an AI-Enabled Route Scouting Service to address these hurdles.
Our service utilizes advanced computer-aided synthesis planning (CASP) technology. By combining proprietary data with powerful AI tools, we help process chemists identify the most efficient and effective synthetic routes for your API. This streamlined approach:
- Optimizes Route Selection: We identify the best pathways to minimize synthetic steps and improve overall efficiency.
- Accelerates Development: Shorten timelines and get your molecules to the clinic faster.
- Strengthens Supply Chain Strategies: Enhance your ability to reliably and efficiently supply your API.
This webinar will explore how Lonza's customized approach can help you overcome the challenges of API complexity, improve process efficiency, and add significant value to your pharmaceutical development program.